Capitol Clarity / Firms / Paratek Pharmaceuticals

Paratek Pharmaceuticals

Paratek Pharmaceuticals lobbies on its own behalf. For Q3 2026 it reported $20K across 1 client report and lists 1 lobbyist across its filings. Issues include Budget/Appropriations.

Clients, Q3 2026

ClientReportedIssues
PARATEK PHARMACEUTICALS$20KBudget/Appropriations

By year

YearReportedClients
2026$60K1
2025$70K1

Lobbyists listed

Amounts are the filer's good-faith estimates, per report, and cannot be split by issue. See the Capitol Clarity rankings and method.